secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001104659-25-027233
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cara issues supplemental disclosures for Tvardi merger after stockholder lawsuits
--------------------------------------------------------------------------------

- Received 13 demands and 2 lawsuits (filed Mar 5-6, 2025) claiming proxy omitted material info.
- Combined company board to have 5 Tvardi designees, 1 Cara designee (Susan Shiff), 1 vacancy.
- Piper Sandler valuation analyses updated with detailed peer comparisons and IPO precedent tables.
- Cara denies violations but provides supplements to avoid litigation expense and merger disruption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465925027233/0001104659-25-027233-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465925027233/tm259994d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-027233

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer